News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK), Pfizer Inc. (PFE) Extend Cut-price Pneumonia Vaccine Deal


12/19/2011 8:26:36 AM

Pfizer and GlaxoSmithKline are increasing sales of cut-price pneumonia vaccine to developing countries by more than 50 percent, marking the scale-up of an international program to protect millions of children. The Global Alliance for Vaccines and Immunisation (GAVI) is buying an additional 180 million doses of Pfizer's pneumococcal vaccine Prevenar 13 and a similar quantity of GSK's Synflorix at a deeply discounted price of $3.50 a shot. The two companies said on Friday they would supply the extra vaccine through 2023, building on an original commitment last year to supply 300 million doses apiece.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES